Recent studies have indicated TOPK expression is a poor prognostic factor in cancers of the lung, ovary, kidney, colon, as well as leukemia, glioblastoma, and melanoma [11, 14, 15, 16, 17, 18, 19, 39]. This evidence concerns the gene PBK and glioblastoma.